Ectopic Adipose Tissue, Exercise Training and IL-6

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Adiposity
Interventions
BEHAVIORAL

Endurance Exercise Training

Three months of supervised training. Interval training, 3 sessions weekly of 45 min. During intervals the intensity will be minimum 70 % of VO2 max

BEHAVIORAL

Resistance Exercise Training

Three months of supervised resistance training. Subjects will perform 3 weekly sessions of 45 min. The intensity will be kept at minimum 60% of 1RM.

BEHAVIORAL

No Exercise

Control to exercise

DRUG

Tocilizumab

Tocilizumab infusion will be administered monthly (8 mg/kg body weight i.v., maximun 800 mg). Each subject will receive 3 infusions during the study period.

DRUG

Placebo

Saline infusion will be administered monthly (same volume as Tocilizumab). Each subject will receive 3 infusions during the study period.

Trial Locations (1)

2100

Rigshospitalet, Centre of Inflammation and Metabolism (CIM) Centre for Physical Activity Research (CFAS), Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT02901496 - Ectopic Adipose Tissue, Exercise Training and IL-6 | Biotech Hunter | Biotech Hunter